- Home
- RVNC vs MMT Comparison
RVNC vs MMT Comparison
Compare RVNC & MMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVNC
- MMT
- Stock Information
- Founded
- RVNC 1999
- MMT 1987
- Country
- RVNC United States
- MMT United States
- Employees
- RVNC N/A
- MMT N/A
- Industry
- RVNC Biotechnology: Pharmaceutical Preparations
- MMT Trusts Except Educational Religious and Charitable
- Sector
- RVNC Health Care
- MMT Finance
- Exchange
- RVNC Nasdaq
- MMT Nasdaq
- Market Cap
- RVNC 320.5M
- MMT 270.5M
- IPO Year
- RVNC 2014
- MMT N/A
- Fundamental
- Price
- RVNC $3.09
- MMT $4.59
- Analyst Decision
- RVNC Hold
- MMT
- Analyst Count
- RVNC 9
- MMT 0
- Target Price
- RVNC $8.45
- MMT N/A
- AVG Volume (30 Days)
- RVNC 3.6M
- MMT 86.5K
- Earning Date
- RVNC 11-07-2024
- MMT 01-01-0001
- Dividend Yield
- RVNC N/A
- MMT 8.58%
- EPS Growth
- RVNC N/A
- MMT N/A
- EPS
- RVNC N/A
- MMT 0.30
- Revenue
- RVNC $256,945,000.00
- MMT N/A
- Revenue This Year
- RVNC $11.28
- MMT N/A
- Revenue Next Year
- RVNC $27.21
- MMT N/A
- P/E Ratio
- RVNC N/A
- MMT $15.33
- Revenue Growth
- RVNC 25.82
- MMT N/A
- 52 Week Low
- RVNC $2.30
- MMT $4.04
- 52 Week High
- RVNC $9.75
- MMT $4.70
- Technical
- Relative Strength Index (RSI)
- RVNC 33.47
- MMT 27.52
- Support Level
- RVNC $3.06
- MMT $4.72
- Resistance Level
- RVNC $3.09
- MMT $4.77
- Average True Range (ATR)
- RVNC 0.11
- MMT 0.03
- MACD
- RVNC 0.02
- MMT -0.02
- Stochastic Oscillator
- RVNC 6.90
- MMT 12.70
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.
About MMT MFS Multimarket Income Trust
MFS Multimarket Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income, but may also consider capital appreciation. The fund invests a majority of its net assets in fixed-income securities, corporate bonds of the U.S and foreign issuers, U.S Government securities, foreign government securities, mortgage-backed and other asset-backed securities of U.S and foreign issuers, and debt instruments of issuers located in emerging market countries. The portfolio of investments comprises of different sector investments such as aerospace, airlines, automotive, chemicals, electronics, and others.